Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical Imaging

PUBLISHER: Grand View Research | PRODUCT CODE: 1552871

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1552871

Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share & Trends Analysis Report By Modality (Computed Tomography, X rays, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Coronary Heart Disease Diagnostic Imaging Devices Market Growth & Trends:

The global coronary heart disease diagnostic imaging devices market size is expected to reach USD 2.96 billion by 2030, registering a CAGR of 6.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increase in coronary diseases and deaths associated with it calls for better and early diagnosis of the condition. Precise scan interpretation and technologically advanced equipment are the factors influencing the market growth. Various imaging modalities are useful in identifying unique aspects of coronary screening. For instance, intravascular ultrasound, X-ray angiography, and computed tomography angiography (CTCA) provide a direct evaluation and quantification of alterations in the coronary arteries. However, non-invasive techniques like single-photon computed tomography (SPECT) and positron emission tomography (PET) provide indirect information on CHD by estimating the myocardial perfusion and metabolism abnormalities that are consequent of coronary artery disease.

Technological advancement in this field had led to the development of sharp camera units consisting of gamma systems, that use semiconductor detectors of cadmium zinc telluride (CZT). This led to faster acquisition of images, reduced capture time, high image quality, and lower radiation dose (1mSv for a single injection), as compared to conventional myocardial perfusion imaging by SPECT. Further, improvements around Computed Tomography, to develop non-invasive techniques have also shown great future growth in this segment. However, economic barriers, subject literacy, and lack of medical staff hold back the implementation of such advanced techniques in real practice.

The coronary heart disease diagnostic imaging devices market saw a sharp decline in 2020, due to the outbreak of the COVID-19 pandemic. Fear of virus spread, the shift in focus on diagnosing and treating COVID-19 affected patients, reduced admission rates at hospitals for other diseases, and reduced medical staff, led to the reduction in the diagnosis of CVD. Economic setback observed by end-users also influenced the adoption of advanced techniques to effectively diagnoses coronary alterations. Further, the shutting down of manufacturing units, due to national lockdowns, halt in logistics, and reduction in salesforce also impacted the market negatively. However, diabetic and hypertensive patients witnessed a severe risk of CVD ultimately leading to death. Thus, the pandemic significantly impacted the market in 2020, which is likely to stabilize and grow exponentially by 2022.

Coronary Heart Disease Diagnostic Imaging Devices Market Report Highlights:

  • Nuclear medicine dominated the modality segment due to the ease of image interpretation and accuracy in detection.
  • Computed tomography held the highest CAGR of 7.34% due to its advantages of early detection of even the most intricate alterations which otherwise is impossible to det4ect in the traditional SPECT technology.
  • Asia Pacific is anticipated to be growing at the fastest CAGR over the forecast period owing to the increase in R&D activities and numerous resellers.
Show more
Product Code: GVR-4-68039-924-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary Heart Disease Diagnostic Imaging Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing Prevalence Of Coronary Artery Diseases
      • 3.2.1.2. Rising Adoption Of Early Diagnostic Techniques
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack Of Skilled Radiologists
  • 3.3. Coronary Heart Disease Diagnostic Imaging Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Coronary Heart Disease Diagnostic Imaging Device Market: Modality Estimates & Trend Analysis

  • 4.1. Global Coronary Heart Disease Diagnostic Imaging Device Market: Modality Dashboard
  • 4.2. Global Coronary Heart Disease Diagnostic Imaging Device Market: Modality Movement Analysis
  • 4.3. Global Coronary Heart Disease Diagnostic Imaging Device Market by Modality, Revenue
  • 4.4. Computed Tomography
    • 4.4.1. Computed Tomography market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. X rays
    • 4.5.1. X rays market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Ultrasound
    • 4.6.1. Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Magnetic Resonance Imaging
    • 4.7.1. Magnetic Resonance Imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Nuclear Medicine
    • 4.8.1. Nuclear Medicine market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Coronary Heart Disease Diagnostic Imaging Device Market: Regional Estimates & Trend Analysis by Modality

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. List of key distributors and channel partners
    • 6.2.2. Key customers
    • 6.2.3. Key company market share analysis, 2023
    • 6.2.4. GE Healthcare
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Koninklijke Phillips N.V.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Canon
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Siemens Healthineers AG
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Ziehm Imaging GmbH
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Esaote SPA
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Hitachi Medical Corporation
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. SAMSUNG
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. FUJIFILM Holdings Corporation
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives
Show more
Product Code: GVR-4-68039-924-2

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 4 U.S. Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 5 Canada Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 6 Mexico Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 7 Europe Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 9 Germany Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 10 UK Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 11 France Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 12 Italy Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 13 Spain Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 14 Denmark Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 15 Sweden Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 16 Norway Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 19 China Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 20 Japan Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 21 India Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 22 South Korea Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 23 Australia Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 24 Thailand Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 25 Latin America Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Latin America Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 27 Brazil Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 28 Argentina Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 29 MEA Coronary heart disease diagnostic imaging devices market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 31 South Africa Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 33 UAE Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)
  • Table 34 Kuwait Coronary heart disease diagnostic imaging devices market, by modality, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Coronary heart disease diagnostic imaging devices market: market outlook
  • Fig. 14 Coronary heart disease diagnostic imaging devices competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Coronary heart disease diagnostic imaging devices market driver impact
  • Fig. 18 Coronary heart disease diagnostic imaging devices market restraint impact
  • Fig. 19 Coronary heart disease diagnostic imaging devices market: Modality movement analysis
  • Fig. 20 Coronary heart disease diagnostic imaging devices market: Modality outlook and key takeaways
  • Fig. 21 Computed Tomography market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 X rays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Ultrasound market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Magnetic resonance imaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Nuclear medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global Coronary heart disease diagnostic imaging devices market: Regional movement analysis
  • Fig. 27 Global Coronary heart disease diagnostic imaging devices market: Regional outlook and key takeaways
  • Fig. 28 Global Coronary heart disease diagnostic imaging devices market share and leading players
  • Fig. 29 North America, by country
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. key country dynamics
  • Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada key country dynamics
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico key country dynamics
  • Fig. 36 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK key country dynamics
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany key country dynamics
  • Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 France key country dynamics
  • Fig. 43 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Italy key country dynamics
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain key country dynamics
  • Fig. 47 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark key country dynamics
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden key country dynamics
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Norway key country dynamics
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 China key country dynamics
  • Fig. 56 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan key country dynamics
  • Fig. 58 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India key country dynamics
  • Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand key country dynamics
  • Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea key country dynamics
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Australia key country dynamics
  • Fig. 66 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil key country dynamics
  • Fig. 69 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina key country dynamics
  • Fig. 71 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa key country dynamics
  • Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia key country dynamics
  • Fig. 76 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 UAE key country dynamics
  • Fig. 78 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Kuwait key country dynamics
  • Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Market share of key market players - Coronary heart disease diagnostic imaging devices market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!